Iranian Journal of Medical Sciences

Iranian Journal of Medical Sciences

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Journal Team

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

Journal Metrics

Bayesian Spatial Analysis of the Incidence Rate of Patients with Breast Cancer in Southern Iran

Articles InPress

Document Type : Original Article(s)

Authors

1 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran

4 Shiraz Population Based Cancer Registry, Shiraz University of Medical Sciences, Shiraz, Iran

5 Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

10.30476/ijms.2024.102475.3546

Abstract

Background: In the female population, breast cancer is the most common cancer and a leading cause of cancer death. This study was designed to investigate the geographical pattern of breast cancer risk in different counties of Fars province in the south of Iran from 2001 to 2018.
Methods: In this historical cohort study, data of Shiraz Population-Based Cancer Registry between 2001 and 2018 was used. The geographical variations of breast cancer incidence rate in 36 counties of Fars province were analyzed using the Bayesian spatiotemporal model. 
Results: Overall, the averages of relative risk (RR), temporal trend (TT), and δi for breast cancer were 1.59, 1.025, and 0.00 in the total female population; 1.21, 1.002, and 0.00 in the young female population (under 40 years of age); and 1.54, 1.02, and 0.00 in the female population with invasive ductal carcinoma (IDC), respectively. The steady increase in RR of breast cancer and IDC during 2001-2018 was observed in most counties located in the non-central part of the Fars geographic map. Moreover, a steady increase of young breast cancer RR was observed mainly in southern regions and some northern cities of Fars province. 
Conclusion: Between 2001 and 2018 in Fars province, a steady annual increase of approximately 2% was observed in the total female population for all types of breast cancer, including IDC. High-risk areas, TTs, and changing patterns of breast cancer incidence were determined in this region. Furthermore, areas with a high risk of young breast cancer were identified, which requires special attention.

Keywords

References
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. doi: 10.3322/caac.21492. PubMed PMID: 30207593.
  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108. doi: 10.3322/caac.21262. PubMed PMID: 25651787.
  3. Zare N, Doostfatemeh M, Rezaianzadeh A. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran. Asian Pac J Cancer Prev. 2012;13:1533-7. doi: 10.7314/apjcp.2012.13.4.1533. PubMed PMID: 22799361.
  4. Goli A, Oroei M, Jalalpour M, Faramarzi H, Askarian M. The Spatial Distribution of Cancer Incidence in Fars Province: A GIS-Based Analysis of Cancer Registry Data. Int J Prev Med. 2013;4:1122-30. PubMed PMID: 24319551; PubMed Central PMCID: PMCPMC3843298.
  5. Hosseini-Bensenjan M, Vardanjani HM, Haghpanah S, Khosravizadegan Z, Bagheri-Lankarani K. Investigating Trends of Incidence Rates of Esophageal Cancer Divided by Squamous Cell Carcinoma and Adenocarcinoma in Southern Iran: a 10-Year Experience. J Gastrointest Cancer. 2022;53:230-4. doi: 10.1007/s12029-021-00764-1. PubMed PMID: 34855123.
  6. Hosseini-Bensenjan M, Vardanjani HM, Khosravizadegan Z, Bagheri-Lankarani K. Incidence Trends of Gastric Cancer in Southern Iran: Adenocarcinoma and Non-cardia Gastric Cancer Are More Rising Among Younger Ages. J Gastrointest Cancer. 2022;53:841-7. doi: 10.1007/s12029-021-00722-x. PubMed PMID: 34792757.
  7. Zahedi R, Molavi Vardanjani H, Baneshi MR, Haghdoost AA, Malekpour Afshar R, Ershad Sarabi R, et al. Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis. BMC Womens Health. 2020;20:53. doi: 10.1186/s12905-020-00903-z. PubMed PMID: 32183824; PubMed Central PMCID: PMCPMC7079343.
  8. Mehrabani D, Almasi A, Farahmand M, Ahrari Z, Rezaianzadeh A, Mehrabani G, et al. Incidence of breast cancer in fars province, southern iran: a hospital-based study. World J Plast Surg. 2012;1:16-21. PubMed PMID: 25734039; PubMed Central PMCID: PMCPMC4344961.
  9. Akbari ME, Sayad S, Sayad S, Khayamzadeh M, Shojaee L, Shormeji Z, et al. Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014. Int J Breast Cancer. 2017;2017:2481021. doi: 10.1155/2017/2481021. PubMed PMID: 29201466; PubMed Central PMCID: PMCPMC5671722.
  10. Vinay K, Abbas AK, Fauston N, Aster JJND. Robbins and Cotran pathologic basis of disease. Philadelphia: Saunders Elsevier Publication; 2005. p. 628-36.
  11. Corben AD. Pathology of invasive breast disease. Surg Clin North Am. 2013;93:363-92. doi: 10.1016/j.suc.2013.01.003. PubMed PMID: 23464691.
  12. Mahdavifar N, Pakzad R, Ghoncheh M, Pakzad I, Moudi A, Salehiniya H. Spatial Analysis of Breast Cancer Incidence in Iran. Asian Pac J Cancer Prev. 2016;17:59-64. doi: 10.7314/apjcp.2016.17.s3.59. PubMed PMID: 27165209.
  13. Ahmadi A, Ramazani R, Rezagholi T, Yavari P. Incidence pattern and spatial analysis of breast cancer in Iranian women: Geographical Information System applications. East Mediterr Health J. 2018;24:360-7. doi: 10.26719/2018.24.4.360. PubMed PMID: 29972230.
  14. Statistical Center of Iran [Internet]. Iran National Census. Tehran: Statistical Center of Iran. c2016. Available from: https://amar.org.ir/english
  15. Lankarani KB, Khosravizadegan Z, Rezaianzadeh A, Honarvar B, Moghadami M, Faramarzi H, et al. Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study. BMC Health Serv Res. 2013;13:169. doi: 10.1186/1472-6963-13-169. PubMed PMID: 23647828; PubMed Central PMCID: PMCPMC3649885.
  16. Molavi Vardajani H, Haghdoost AA, Shahravan A, Rad M. Cleansing and preparation of data for statistical analysis: A step necessary in oral health sciences research. Journal of Oral Health and Oral Epidemiology. 2016;5:171-85.
  17. Lawson AB. Bayesian disease mapping: hierarchical modeling in spatial epidemiology. 3rd New York: Chapman and Hall/CRC; 2018. doi: 10.1201/9781351271769.
  18. Blangiardo M, Cameletti M, Baio G, Rue H. Spatial and spatio-temporal models with R-INLA. Spat Spatiotemporal Epidemiol. 2013;4:33-49. doi: 10.1016/j.sste.2012.12.001. PubMed PMID: 23481252.
  19. Bernardinelli L, Montomoli C. Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk. Stat Med. 1992;11:983-1007. doi: 10.1002/sim.4780110802. PubMed PMID: 1496200.
  20. Spiegelhalter D, Thomas A, Best N, Lunn D. OpenBUGS user manual. Version 2007;3:2007.
  21. Esri R. ArcGIS desktop: release 10. Environmental Systems Research Institute, CA. 2011.
  22. Sharafi Z, Asmarian N, Hoorang S, Mousavi A. Bayesian spatio-temporal analysis of stomach cancer incidence in Iran, 2003–2010. Stochastic environmental research and risk assessment. 2018;32:2943-50. doi: 10.1007/s00477-018-1531-3.
  23. Siddig A, Tengku Din T, Mohd Nafi SN, Yahya MM, Sulong S, Wan Abdul Rahman WF. The Unique Biology behind the Early Onset of Breast Cancer. Genes (Basel). 2021;12. doi: 10.3390/genes12030372. PubMed PMID: 33807872; PubMed Central PMCID: PMCPMC8000244.
  24. Nasim Z, Girtain C, Gupta V, Patel I, Hossain MA. Breast Cancer Incidence and Behavior in Younger Patients: A Study From the Surveillance, Epidemiology and End Results Database. World J Oncol. 2020;11:88-97. doi: 10.14740/wjon1278. PubMed PMID: 32494315; PubMed Central PMCID: PMCPMC7239572.
  25. Fazel A, Hasanpour-Heidari S, Salamat F, Rajaie S, Kazeminezhad V, Naeimi-Tabiei M, et al. Marked increase in breast cancer incidence in young women: A 10-year study from Northern Iran, 2004-2013. Cancer Epidemiol. 2019;62:101573. doi: 10.1016/j.canep.2019.101573. PubMed PMID: 31330422.
  26. Talei A, Tahmasebi S, Akrami M, Zangouri V, Rezaianzadeh A, Arasteh P, et al. The Shiraz Breast Cancer Registry (SBCR): study design and primary reports. Per Med. 2018;15:471-9. doi: 10.2217/pme-2018-0047. PubMed PMID: 30375263.
  27. Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East Journal of Cancer. 2018;9:243-51.
  28. Zhao H. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast. Breast Cancer. 2021;28:187-95. doi: 10.1007/s12282-020-01146-4. PubMed PMID: 32812198.
  29. Rahimzadeh S, Burczynska B, Ahmadvand A, Sheidaei A, Khademioureh S, Pazhuheian F, et al. Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data. PLoS One. 2021;16:e0248723. doi: 10.1371/journal.pone.0248723. PubMed PMID: 33730079; PubMed Central PMCID: PMCPMC7968648.
  30. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569-78. doi: 10.1016/S0140-6736(08)60269-X. PubMed PMID: 18280327.
  31. Coughlin SS, Smith SA. The Insulin-like Growth Factor Axis, Adipokines, Physical Activity, and Obesity in Relation to Breast Cancer Incidence and Recurrence. Cancer Clin Oncol. 2015;4:24-31. doi: 10.5539/cco.v4n2p24. PubMed PMID: 26251693; PubMed Central PMCID: PMCPMC4524449.
  32. Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19:407-17. doi: 10.1016/j.cmet.2014.02.006. PubMed PMID: 24606898; PubMed Central PMCID: PMCPMC3988204.
  33. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, Jr., et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87:1234-45. doi: 10.1038/sj.bjc.6600596. PubMed PMID: 12439712; PubMed Central PMCID: PMCPMC2562507.
  34. Almasi-Hashiani A, Nedjat S, Ghiasvand R, Safiri S, Nazemipour M, Mansournia N, et al. The causal effect and impact of reproductive factors on breast cancer using super learner and targeted maximum likelihood estimation: a case-control study in Fars Province, Iran. BMC Public Health. 2021;21:1219. doi: 10.1186/s12889-021-11307-5. PubMed PMID: 34167500; PubMed Central PMCID: PMCPMC8228908.
  35. Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, et al. Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev. 2010;19:2496-502. doi: 10.1158/1055-9965.EPI-10-0747. PubMed PMID: 20802021; PubMed Central PMCID: PMCPMC3055790.
Iranian Journal of Medical Sciences

Articles InPress, Corrected Proof
Available Online from 31 December 2024
Files
History
  • Received: 05 May 2024
  • Revised: 10 August 2024
  • Accepted: 19 September 2024
Share
How to cite
Statistics